Filing Details

Accession Number:
0000914190-13-000757
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-31 19:47:37
Reporting Period:
2013-10-29
Filing Date:
2013-10-31
Accepted Time:
2013-10-31 19:47:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1195116 Arno Therapeutics Inc ARNI Pharmaceutical Preparations (2834) 522286452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189507 Phd F William Hamilton C/O Arno Therapeutics, Inc.
200 Route 3J, Suite 104
Flemington NJ 08822
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-29 20,833 $0.00 22,079 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2013 Series D Warrants (right to buy) Acquisiton 2013-10-29 20,833 $0.00 20,833 $4.00
Common Stock 2013 Series E Warrants (right to buy) Acquisiton 2013-10-29 20,833 $0.00 20,833 $2.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,833 2013-10-29 2018-10-29 No 4 P Direct
20,833 2013-10-29 2014-10-31 No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $8.00 2019-09-29 3,750 3,750 Direct
Common Stock Stock Option (right to buy) $8.00 2020-11-05 1,250 1,250 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-09-29 3,750 3,750 Direct
2020-11-05 1,250 1,250 Direct
Footnotes
  1. The reported securities are included within 20,833 Issuer units purchased by the Reporting Person for $2.40 per unit. Each unit consists of one share of common stock, a 2013 Series D Warrant to purchase one share of common stock, and a 2013 Series E Warrant to purchase one share of common stock.
  2. Currently exercisable.
  3. Vests in three equal annual installments commencing 11/5/11.